Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Ophthalmic nepafenac use in the Netherlands and Denmark

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Development and validation of a multiple-choice questionnaire-based theoretical test in direct ophthalmoscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Visual acuity and amblyopia prevalence in 11- to 12-year-old Danish children from the Copenhagen Child Cohort 2000

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Macular perfusion velocities in the ocular ischaemic syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Human parallels to experimental myopia? A literature review on visual deprivation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Laser pointer maculopathy - on the rise?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Strabismus Incidence in a Danish Population-Based Cohort of Children

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Andrea V Margulis
  • Eline Houben
  • Jesper Hallas
  • Jetty A Overbeek
  • Anton Pottegård
  • Tobias Torp-Pedersen
  • Susana Perez-Gutthann
  • Alejandro Arana
View graph of relations

PURPOSE: To describe nepafenac use in the Netherlands and Denmark with reference to its approved indications. For context, we also describe the use of ketorolac and diclofenac.

METHODS: We identified users in the PHARMO Database Network (the Netherlands, 2008-2013) and the Danish national health registers (Denmark, 1994-2014). We described prevalence of cataract surgery and duration of use in patients with cataract surgery with and without diabetes.

RESULTS: In the Netherlands, 9530 nepafenac users (mean age, 71 years; 60% women) contributed 12 691 therapy episodes, of which 21% had a recently recorded cataract surgery. Of 2266 episodes in adult non-diabetic patients with cataract surgery, 60% had one bottle dispensed (treatment duration ≤21 days). Of 441 episodes in adult diabetic patients with cataract surgery, 90% had up to two bottles dispensed (≤60 days). Denmark had 60 403 nepafenac users (mean age, 72 years; 58% women) and 73 648 episodes (41% had recorded cataract surgery). Of 26 649 nepafenac episodes in adult non-diabetic patients with cataract surgery, 92% had one bottle dispensed. Of 3801 episodes in adult diabetic patients with cataract surgery, 99.8% had up to two bottles dispensed. Use patterns of nepafenac, ketorolac and diclofenac were roughly similar in the Netherlands, but not in Denmark.

CONCLUSION: Less than half of therapy episodes were related to cataract surgery; around 90% of episodes with surgery were within the approved duration. Underrecording of ophthalmic conditions and procedures was a challenge in this study.

Original languageEnglish
JournalActa Ophthalmologica (Online)
Volume95
Issue number5
Pages (from-to)509-517
Number of pages9
ISSN1755-3768
DOIs
Publication statusPublished - 2017

    Research areas

  • Aged, Anti-Inflammatory Agents, Non-Steroidal, Benzeneacetamides, Cataract Extraction, Denmark, Drug Utilization, Female, Follow-Up Studies, Humans, Incidence, Male, Netherlands, Ophthalmic Solutions, Phenylacetates, Postoperative Complications, Retrospective Studies, Journal Article, Multicenter Study, Observational Study

ID: 52799235